H. Lundbeck A/S acquires Ovation Pharmaceuticals, Inc.

On March 19, 2009, H. Lundbeck A/S acquired Ovation Pharmaceuticals, Inc., a life science company in Illinois, United States, from GTCR LLC.

Deal at a glance

AnnouncedMarch 19, 2009 TypeAdd-on Acquistion TargetOvation Pharmaceuticals, Inc. Buyer H. Lundbeck A/S Seller GTCR LLC SectorLife Science LocationIllinois, United States ValueMembers only

Target company

Ovation Pharmaceuticals, Inc.

Illinois, United States

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

H. Lundbeck A/S

Company · 5 deals on record

1st transaction in life science
1st transaction in United States

5deals, all time

3in this sector

2019latest

Seller

GTCR LLC

Private equity firm · 140 deals on record

140investments

10in this sector

78exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Outcomes One, Inc.Same seller · Sep 2026

AssuredPartners, Inc.Same seller · Aug 2025

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Ovation Pharmaceuticals, Inc.?H. Lundbeck A/S acquired Ovation Pharmaceuticals, Inc. on March 19, 2009.

Who sold Ovation Pharmaceuticals, Inc.?GTCR LLC was the seller.

What type of deal was it?It was a add-on acquistion in the life science sector in 2009.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).